Thomson Medical Group's (SGX:A50) Malaysia-listed unit, TMC Life Sciences (KLSE:TMCLIFE), appointed Ahmad Adzuan Abdul Rahman as group chief executive officer.
Rahman takes over the role from Melvin Heng Jun Li, who has been redesignated from acting group CEO to non-executive director, according to a Monday filing with the Singapore Exchange.
Before joining TMC Life, Rahman was a founding member and advisor of Novotec Group. Prior to that, he was a regional managing director and executive vice president at IDS Medical Systems.